🇺🇸 FDA
Pipeline program

Descartes-11

DC11A

Phase 2 mab terminated

Quick answer

Descartes-11 for Multiple Myeloma is a Phase 2 program (mab) at Cartesian Therapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Multiple Myeloma
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials